The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes associated with chemotherapy-induced neutropenia in the adjuvant treatment of colorectal cancer with FOLFOX.
 
Sara Trincao-Batra
No Relationships to Disclose
 
Rachel Anne Goodwin
Honoraria - Advanced Accelerator Applications; Advanced Accelerator Applications; Eisai; Ipsen; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Apobiologix; Eisai; Incyte; Ipsen; Merck; Pfizer; Taiho Pharmaceutical
Speakers' Bureau - Advanced Accelerator Applications/Novartis; Eisai; Merck; Mylan; Novartis; Pfizer
Research Funding - Eisai; Ipsen
 
Horia Marginean
No Relationships to Disclose
 
Jean Alfred Maroun
No Relationships to Disclose
 
Michael M. Vickers
Honoraria - Amgen; Merck
 
Timothy R. Asmis
No Relationships to Disclose
 
Joanna Gotfrit
No Relationships to Disclose